Verrica Pharmaceuticals Inc. Common Stock
Symbol: VRCA (NASDAQ)
4.58
▼ (-1.95%) -0.091
Company Description:
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
Key Stats
- Today's Open: $4.626
- Today's High: $4.75
- Today's Low: $4.455
- Today's Volume: 58.04K
- Yesterday Close: $4.67
- Yesterday High: $4.72
- Yesterday Low: $4.467
- Yesterday Volume: 57.45K
- Last Min Volume: 5
- Last Min High: $4.579
- Last Min Low: $4.476
- Last Min VWAP: $4.476
Company Profile
- Name: Verrica Pharmaceuticals Inc. Common Stock
- Website: https://www.verrica.com
- Listed Date: 2018-06-15
- Location: WEST CHESTER, PA
- Market Status: Active
- CIK Number: 0001660334
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $44.11M
- Round Lot: 100
- Outstanding Shares: 9.45M
- Asset Type: CS
RECENT FILINGS FOR VRCA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-07-30 | 8-K | View |
| 2025-07-23 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-12 | 8-K | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-05 | 8-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-13 | S-8 | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-30 | DEFR14A | View |
| 2025-04-25 | 8-K | View |
| 2025-04-22 | ARS | View |
Latest News on VRCA